INVESTMENT IN UNCONSOLIDATED AFFILIATE	9 Months Ended
INVESTMENT IN UNCONSOLIDATED AFFILIATE	Dec. 31, 2012
INVESTMENT IN UNCONSOLIDATED AFFILIATE [Abstract]
INVESTMENT IN UNCONSOLIDATED AFFILIATE	NOTE 6. INVESTMENT IN UNCONSOLIDATED AFFILIATE Our investment in an unconsolidated affiliate consists of an investment in equity securities of Scandinavian Micro Biodevices APS ("SMB"). In February 2011, we purchased a 15% equity ownership interest in SMB, for $2.8 million in cash. SMB is a privately-held developer and manufacturer of point-of-care diagnostic products for veterinary use. SMB, based in Farum, Denmark, has been the original equipment manufacturer of the Abaxis VetScan VSpro point-of-care specialty analyzer since 2008. Abaxis has had exclusive distribution rights for the analyzer and associated cartridges in North America since 2008. Starting January 2011, Abaxis has non-exclusive rights in other areas of the world. We accounted for our investment in SMB using the equity method due to our significant influence over SMB's operations. Our allocated portions of SMB's net income (loss) during the three months ended December 31, 2012 and 2011 were $21,000 and $(29,000), respectively, and during the nine months ended December 31, 2012 and 2011 were $(13,000) and $(101,000), respectively.

The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.

+ References+ Details